Uses of formulations of thyroid hormone antagonists and nanoparticulate forms thereof to increase chemosensivity and radiosensitivity in tumor or cancer cells
WO2011028897A1
Methods for identifying a virulent strain of virus
WO2011020089A2
Target genes for cancer therapy
WO2011009089A1
SMALL NON-CODING REGULATORY RNAs AND METHODS FOR THEIR USE
CA2765792A1
Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof
WO2010120506A1
Combination treatment of cancer with cetuximab and tetrac
EP2297338A2
Methods for disease therapy
CA2672270A1
Treatments of therapy resistant diseases and drug combinations for treating the same
EP2059615A2
Prognostic and diagnostic method for disease therapy
WO2007130469A2
Induction of intracellular and secreted growth inhibitors and paracrine tumor-suppressive activity by rar ligands
CA2648243A1
Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof
CA2648021A1
Prognostic and diagnostic method for cancer therapy
US2010209382A1
Polyphenol Conjugates as RGD-Binding Compounds and Methods of Use
WO2006127731A2
Inhibitors of pghs-2transactivator activity
US2006217305A1
Induction of tumor cell senescence by retinoid receptor agonists and antagonists
